Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Partial Redemption Of Non-Convertible Debentures

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures (NCDs) of Rs 25 crores (Rupees Twenty Five Crores) out of the total NCDs of Rs 195 crores (Rupees One Hundred Ninety Five Crores) issued under ISIN: INE685A07108 has been redeemed and repaid by the Company on 23-Apr-21.
23-04-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Issue of Duplicate Share Certificate
21-04-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Shareholding for the Period Ended March 31, 2021

 Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
20-04-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015

 With reference to the above, we send herewith a copy of the Compliance Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 issued by the Practicing Company Secretary, Rajesh Parekh & Co., Ahmedabad in respect of transfer of securities of the Company during the half year ended on 31st March, 2021. Kindly find the same in order.
13-04-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half Year Ended On 31St March, 2021

 In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for half year ended on 31st March, 2021.
13-04-2021

Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan

 Net Sales are expected to increase by 4.6 percent Y-o-Y (up 1.5 percent Q-o-Q) to Rs. 2,000.7 crore, according to Sharekhan.
12-04-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer
08-04-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Issue of Duplicate Share Certificates
05-04-2021
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

 Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
01-04-2021
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

 Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
31-03-2021
Next Page
Close

Let's Open Free Demat Account